62
Participants
Start Date
September 30, 2006
Primary Completion Date
November 30, 2010
Study Completion Date
June 30, 2011
Iloprost PD-6
Period I: Patients received iloprost administered using PD-6 for the 37 days prior to the first dosing of iloprost using PD-15. Iloprost inhalation solution was delivered using the I-neb® AAD System. Patients were required to use their own I-neb®.
Iloprost PD-15
Period II: Iloprost inhalation solution was delivered using the investigational product PD-15 with I-neb® AAD System for 37 days. Patients were required to use their own I-neb®.
Columbia University Medical Center, New York
New York Presbyterian Hospital, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Maryland Hospital, Baltimore
Duke University Medical Center, Durham
University of Iowa Hospital and Clinics, Iowa City
Aurora Medical Group - Cardiovascular Services, Milwaukee
Ochsner Clinic Foundation, New Orleans
Baylor College of Medicine, Houston
Diagnostic Research Group, San Antonio
Pulmonary Associates, Phoenix
UCSD Medical Center, Thorton Hospital, La Jolla
Lead Sponsor
Actelion
INDUSTRY